Renal and Haematological Toxicity in patients undergoing Lu-177-DOTATATE Capecitabine therapy for NeuroEndocrine Tumors

被引：0
|
作者：
Mohan, A. [1 ]
Sood, A. [1 ]
Bhusari, P. [1 ]
Mittal, B. [1 ]
机构：
[1] Post Grad Inst Med Educ & Res, Chandigarh, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-572
引用
收藏
页码：S185 / S185
页数：1
相关论文
共 50 条
  • [1] A clinical score for neuroendocrine tumor patients under consideration for Lu-177-DOTATATE therapy
    Das, Satya
    Du, Liping
    Schad, Aimee
    Jain, Shikha
    Jessop, Aaron
    Shah, Chirayu
    Eisner, David
    Cardin, Dana
    Ciombor, Kristen
    Goff, Laura
    Bradshaw, Marques
    Delbeke, Dominique
    Sandler, Martin
    Berlin, Jordan
    ENDOCRINE-RELATED CANCER, 2021, 28 (03) : 203 - 212
  • [2] Long Term Renal and Haematological Side Effects in NET Patients Treated with Lu-177-DOTATATE
    Oturai, P.
    De Nijs, R.
    Klausen, T.
    Holm, S.
    Knigge, U.
    Mortensen, J.
    NEUROENDOCRINOLOGY, 2016, 103 : 83 - 83
  • [3] Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE
    Pretot, Dominique
    Engel-Bicik, Ivette
    Kenkel, David
    Kaufmann, Philipp A.
    Treyer, Valerie
    Siebenhuner, Alexander R.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (03) : 1204 - 1217
  • [4] Renal and Hematological Toxicity in Patients of Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
    Gupta, Santosh K.
    Singla, Suhas
    Bal, Chandrasekhar
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (09) : 593 - 599
  • [5] Lu-177-DOTATATE Peptide Receptor Radionuclide Therapy
    Abbott, Amanda
    Jacene, Heather
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2018, 46 (03) : 245 - 246
  • [6] Toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors
    Bonilla Plaza, J.
    Martinez Lorca, A.
    Navarro Martinez, T.
    Ajuria Illarramendi, O.
    Lopez Villar, I.
    Azpeitia Hernandez, P.
    Gutierrez Guerrero, M.
    Paredes Rodriguez, P.
    Orduna Diez, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S471 - S471
  • [7] Effect of Absorbed Dose on Toxicity and Tumor Response in Patients With Gastroenteropancreatico Neuroendocrine Tumors Treated with Lu-177-DOTATATE in Combination with Olaparib: Preliminary Results
    Lin, F.
    Shamis, I.
    Zou, J.
    Carrasquillo, J.
    Maass-Moreno, R.
    Cedo, M.
    Carreon, J.
    Eclarinal, P.
    Turkbey, B.
    Mena, E.
    Lindenberg, L.
    Chen, C.
    Millo, C.
    Herscovitch, P.
    Pacak, K.
    del Rivero, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S210 - S210
  • [8] Lu-177-Dotatate therapy for the treatment of metastatic neuroendocrine tumours in a patient on haemodialysis - dosimetric considerations
    Kalogianni, Eleni
    Ruiz, Danielle Louise
    Corcoran, Benjamin James
    Devlin, Lindsey Ann
    Vivian, Gillian Claire
    Mulholland, Nicola Jane
    BJR CASE REPORTS, 2015, 1 (03):
  • [9] Lu-177-DOTATATE PRRT in Patients with Metastatic Neuroendocrine Tumor and a Single Functioning Kidney: Tolerability and Effect on Renal Function
    Ranade, Rohit
    Basu, Sandip
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2016, 44 (02) : 65 - 69
  • [10] 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Ozdemir, Nuriye Y.
    Arslan, Suheyla A.
    Sendur, Mehmet A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1391 - 1391
12345